{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:38:16Z","timestamp":1791005896257,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.nmd.2013.03.014","type":"journal-article","created":{"date-parts":[[2013,4,29]],"date-time":"2013-04-29T20:30:46Z","timestamp":1367267446000},"page":"599-601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Myocardial infarction after rituximab infusion"],"prefix":"10.1016","volume":"23","author":[{"given":"Dimitri","family":"Renard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Cornillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Castelnovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2013.03.014_b0005","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/jnnp.2009.197632","article-title":"The use of rituximab in myasthenia gravis and Lambert\u2013Eaton myasthenic syndrome","volume":"82","author":"Maddison","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2013.03.014_b0010","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/mus.23412","article-title":"Rituximab in refractory and non-refractory myasthenia: a retrospective multicenter study","volume":"46","author":"Collongues","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2013.03.014_b0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1200\/JCO.2000.18.2.317","article-title":"European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma","volume":"18","author":"Foran","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nmd.2013.03.014_b0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3816\/CLM.2008.n.035","article-title":"Acute coronary syndromes complicating the first infusion of rituximab","volume":"8","author":"Armitage","year":"2008","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.1016\/j.nmd.2013.03.014_b0025","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4103\/0973-1482.87003","article-title":"Rituximab induced myocardial infarction: a fatal drug reaction","volume":"7","author":"Arunprasath","year":"2011","journal-title":"J Cancer Res Ther"},{"issue":"99","key":"10.1016\/j.nmd.2013.03.014_b0030","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jnci\/djk029","article-title":"Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study","volume":"7","author":"Swerdlow","year":"2007","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.nmd.2013.03.014_b0035","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.3748\/wjg.v12.i38.6235","article-title":"Acute coronary syndrome after infliximab therapy in a patient with Crohn\u2019s disease","volume":"14","author":"Panteris","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.nmd.2013.03.014_b0040","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1034\/j.1600-0609.2002.00712.x","article-title":"Severe cardiac toxicity after monoclonal antibody therapy","volume":"68","author":"Damaj","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.nmd.2013.03.014_b0045","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/01.crd.0000178320.51474.ac","article-title":"Acute coronary syndrome after infliximab infusion","volume":"14","author":"Abedin","year":"2006","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.nmd.2013.03.014_b0050","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ejim.2012.06.016","article-title":"Inflammatory arthritis as a novel risk factor for cardiovascular disease","volume":"23","author":"John","year":"2012","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.nmd.2013.03.014_b0055","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.atherosclerosis.2006.05.019","article-title":"Use of oral corticosteroids and the risk of acute myocardial infarction","volume":"192","author":"Varas-Lorenzo","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.nmd.2013.03.014_b0060","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","volume":"107","author":"Chung","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.nmd.2013.03.014_b0065","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/01.CIR.97.14.1392","article-title":"Tumor necrosis factor-alpha confers resistance to hypoxic injury in the adult mammalian cardiac myocyte","volume":"97","author":"Nakano","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.nmd.2013.03.014_b0070","first-page":"H1231","article-title":"Tumor necrosis factor-alpha-induced expression of heat shock protein 72 in adult feline cardiac myocytes","volume":"270","author":"Nakano","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.nmd.2013.03.014_b0075","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s10495-007-0108-2","article-title":"TNFalpha-initiated oxidative\/nitrative stress mediates cardiomyocyte apoptosis in traumatic animals","volume":"12","author":"Li","year":"2007","journal-title":"Apoptosis"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896613001168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896613001168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:01:27Z","timestamp":1760774487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896613001168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0960896613001168"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2013.03.014","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myocardial infarction after rituximab infusion","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2013.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}